Conference Coverage

VIDEO: Encouraging results reported for novel Huntington’s disease therapy

Publish date: April 23, 2018

 

REPORTING FROM AAN 2018


The clinical results are exploratory and require confirmation in larger studies, Dr. Tabrizi stressed.

The study was supported by Ionis Pharmaceuticals. Roche will develop the drug in further clinical trials.

SOURCE: Tabrizi S et al. AAN 2018 abstract CT.002.

Pages

Recommended Reading

Driving ability of Parkinson’s patients can decline quickly
MDedge Psychiatry
In Lewy body disease, CSF may reveal dementia risk
MDedge Psychiatry
Salivary biomarker identified for Huntington’s disease
MDedge Psychiatry
High-intensity treadmill workouts preserved motor function in early-stage Parkinson’s
MDedge Psychiatry
Gene silencer reduces mutant huntingtin protein in early-stage Huntington’s patients
MDedge Psychiatry
Corynebacterium in the gut can trigger Parkinson’s disease
MDedge Psychiatry
Low caffeine in blood could be marker of early Parkinson’s
MDedge Psychiatry
Mutations on LRRK2 gene modify risks for both Crohn’s and Parkinson’s
MDedge Psychiatry
MDedge Daily News: Could gut bacteria trigger lupus?
MDedge Psychiatry
Psychiatric subspecialty is changing its name
MDedge Psychiatry